Search Results

January 27, 2022

Johnson & Johnson Marks More Than 2 Billion Doses of Medicine Donated to Date to Help Combat Intestinal Worms

Millions of children in more than 50 countries have received deworming medication since the donation program began in 2006, enabling them to grow and thrive The Company continues to build upon its longstanding commitment to address neglected tropical diseases through R&D efforts targeting dengue and leprosy

Innovative Medicine

January 26, 2022

A Newly Published Network Meta-Analysis (NMA) Found TREMFYA® (guselkumab) Ranked Highest for Overall Level of Skin Clearance and Provided Positive Joint Efficacy Among Active Psoriatic Arthritis (PsA) Therapies

The NMA indirectly compared all published Phase 3 data for approved treatments for adults with active PsA TREMFYA ranked highest among 23 active PsA treatment regimens on skin clearance (PASI 90 response) and showed positive joint efficacy (ACR20), including inhibition of structural damage (vdH-S)

What you need to know about Johnson & Johnson’s 2021 fourth-quarter and full-year earnings report

Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Consumer Health, Pharmaceutical and Medical Devices businesses.

Financial

January 25, 2022

Johnson & Johnson Reports Q4 and Full-Year 2021 Results

2021 Fourth-Quarter Sales of $24.8 Billion reflecting growth of 10.4%, operational sales growth of 11.6%*, and adjusted operational sales growth of 12.3%* 2021 Full-Year Sales of $93.8 Billion reflecting growth of 13.6%, operational sales growth of 12.2%*, and adjusted operational sales growth of 12.8%* 2021 Fourth-Quarter EPS of $1.77 increased 172.3%; adjusted EPS of $2.13 increased 14.5%* 2021 Full-Year EPS of $7.81 increased 41.7%; adjusted EPS of $9.80 increased 22.0%* Company guides 2022 adjusted operational sales growth of 7.7%* and adjusted operational EPS growth of 9.2%*

Health & wellness

January 24, 2022

How a support group went virtual to help kids cope with COVID-19 anxiety

As the pandemic spread, many young people experienced anger, stress—even depression. But a Save the Children initiative supported by Johnson & Johnson is teaching them how to manage their difficult emotions.

Global Health Equity

January 19, 2022

Bringing healthcare to remote villages in India and serving as a role model for girls

The Auxiliary Nurses and Midwives Training Program at the Indian Red Cross Society’s Bel Air College of Nursing in Maharashtra, India, is addressing the acute shortage of nurses in rural villages and providing women with employment.

Health & wellness

January 18, 2022

4 things to know about the flu in the time of COVID-19

How can you tell which virus is causing your cough or fever? Is it too late to get a flu shot if you haven’t? A Johnson & Johnson expert addresses these questions—and how the company is working to improve the future of flu prevention.

January 14, 2022

Johnson & Johnson Statement on New Mexico Opioid Settlement Agreement

Medical technologies

January 13, 2022

U.S. FDA Approves New MENTOR® MemoryGel BOOST™ Breast Implant

Implant provides the natural feel patients desire with increased form stability to shape the breast Recent study shows patients and surgeons both preferred the MENTOR® MemoryGel BOOST™ Breast Implant as feeling more like a natural breast versus another leading brand

Search Results

No Results

Search Results